(Alliance News) - GSK PLC on Thursday said its monoclonal antibody Nucala, also known as mepolizumab, has been accepted for review in China.

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix for the prevention of shingles.

Ensure smooth GST registration with Aadhaar authentication or biometric verification as per Rule 8 of the CGST Rules, ...

(Alliance News) - GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment for shingles. The Brentford, England-based pharmaceutical ...

Teva Pharmaceutical Industries Ltd. ADR-0.93% $19.32B ...

(Alliance News) - GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment for shingles. The Brentford, England-based pharmaceutical and ...

GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment ... Subscribe now to see this Premium News article from Alliance News ...

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. Glycogen synthase kinase 3β (GSK-3β) plays a pivotal role in AD pathogenesis, ...

1. Rule 8 of the CGST Rules, 2017 has been amended to provide that an applicant can be identified on the common portal, based on data analysis and risk parameters for Biometric-based Aadhaar ...

EMA has accepted GSK’s application for a prefilled syringe presentation of Shingrix for review. Credit: Vivida Photo PC/Shutterstock. GSK and the University of Oxford have entered a new research ...